Imipenem Monohydrate from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

Imipenem Monohydrate Chemicals

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
Imipenem Monohydrate

Description

Imipenem

Product Specs
ItemImipenem Monohydrate
CompanySanta Cruz Biotechnology, Inc.
Price $122.00Supplier Page View Company Product Page
Catalog Numbersc-205350
Quantity25 mg
TypeBiochemical Reagents
Molecular Weight317.36

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Stability of 10 Beta-Lactam Antibiotics in Human Plasma at Different Storage ConditionsTherapeutic drug monitoringOctober 1, 2023Bahmany S, Ewoldt TMJ, Abdulla A, Koch BCP.

(2) Synergistic antibacterial activity of silver nanoparticles biosynthesized by carbapenem-resistant Gram-negative bacilliScientific reportsSeptember 9, 2022Haji SH, Ali FA, Aka STH.

(3) Chemogenomic Screen for Imipenem Resistance in Gram-Negative BacteriamSystemsNovember 19, 2019El Khoury JY, Maure A, Gingras H, Leprohon P, Ouellette M.

(4) Burkholderia pseudomallei acquired ceftazidime resistance due to gene duplication and amplificationInternational journal of antimicrobial agentsMay 1, 2019Chirakul S, Somprasong N, Norris MH, Wuthiekanun V, Chantratita N, Tuanyok A, Schweizer HP.

(5) Investigation of class-d beta-lactamases causing carbapenem resistance in clinical Acinetobacter baumannii isolatesTurkish journal of medical sciencesNovember 13, 2017Davandeh I, Eraç B, Aydemir SŞ.

(6) Blocking peptidoglycan recycling in Pseudomonas aeruginosa attenuates intrinsic resistance to fosfomycinMicrobial drug resistance (Larchmont, N.Y.)June 1, 2014Borisova M, Gisin J, Mayer C.

(7) Functional Module Connectivity Map (FMCM): a framework for searching repurposed drug compounds for systems treatment of cancer and an application to colorectal adenocarcinomaPloS oneJanuary 1, 2014Chung FH, Chiang YR, Tseng AL, Sung YC, Lu J, Huang MC, Ma N, Lee HC.

Be the First to Write a Review!